KLRS NASDAQ · Healthcare · FY 2025-12-31
Kalaris Therapeutics, Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○
Low · 1/4
Price
3.510 USD
Market cap
80.4M USD
P / B
1.02
P / E
—
EPS
-2.850
DPS / yield
— (0.0%)
NAV / share
3.441
Graham number
—
Z'' score
1.20
Piotroski F
3 / 9
Beneish M
—
ROIC vs WACC
—
vs 12.4%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.